These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 28385800)

  • 1. An Exome-Chip Association Analysis in Chinese Subjects Reveals a Functional Missense Variant of
    Cheung CYY; Tang CS; Xu A; Lee CH; Au KW; Xu L; Fong CHY; Kwok KHM; Chow WS; Woo YC; Yuen MMA; Cherny SS; Hai J; Cheung BMY; Tan KCB; Lam TH; Tse HF; Sham PC; Lam KSL
    Diabetes; 2017 Jun; 66(6):1723-1728. PubMed ID: 28385800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Common missense variant in the glucokinase regulatory protein gene is associated with increased plasma triglyceride and C-reactive protein but lower fasting glucose concentrations.
    Orho-Melander M; Melander O; Guiducci C; Perez-Martinez P; Corella D; Roos C; Tewhey R; Rieder MJ; Hall J; Abecasis G; Tai ES; Welch C; Arnett DK; Lyssenko V; Lindholm E; Saxena R; de Bakker PI; Burtt N; Voight BF; Hirschhorn JN; Tucker KL; Hedner T; Tuomi T; Isomaa B; Eriksson KF; Taskinen MR; Wahlstrand B; Hughes TE; Parnell LD; Lai CQ; Berglund G; Peltonen L; Vartiainen E; Jousilahti P; Havulinna AS; Salomaa V; Nilsson P; Groop L; Altshuler D; Ordovas JM; Kathiresan S
    Diabetes; 2008 Nov; 57(11):3112-21. PubMed ID: 18678614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction effect of genetic polymorphisms in glucokinase (GCK) and glucokinase regulatory protein (GCKR) on metabolic traits in healthy Chinese adults and adolescents.
    Tam CH; Ma RC; So WY; Wang Y; Lam VK; Germer S; Martin M; Chan JC; Ng MC
    Diabetes; 2009 Mar; 58(3):765-9. PubMed ID: 19073768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype effects of glucokinase regulator on lipid profiles and glycemic status are modified by circulating calcium levels: results from the Korean Genome and Epidemiology Study.
    Kim OY; Kwak SY; Lim H; Shin MJ
    Nutr Res; 2018 Dec; 60():96-105. PubMed ID: 30527264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of rare coding variants in the gene encoding human glucokinase regulatory protein with phenotypic, cellular, and kinetic outcomes.
    Rees MG; Ng D; Ruppert S; Turner C; Beer NL; Swift AJ; Morken MA; Below JE; Blech I; ; Mullikin JC; McCarthy MI; Biesecker LG; Gloyn AL; Collins FS
    J Clin Invest; 2012 Jan; 122(1):205-17. PubMed ID: 22182842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of apolipoprotein A5 (APOA5), glucokinase (GCK) and glucokinase regulatory protein (GCKR) polymorphisms and lifestyle factors with the risk of dyslipidemia and dysglycemia in Japanese - a cross-sectional data from the J-MICC Study.
    Hishida A; Morita E; Naito M; Okada R; Wakai K; Matsuo K; Nakamura K; Takashima N; Suzuki S; Takezaki T; Mikami H; Ohnaka K; Watanabe Y; Uemura H; Kubo M; Tanaka H; Hamajima N
    Endocr J; 2012; 59(7):589-99. PubMed ID: 22517333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits.
    Singh C; Jin B; Shrestha N; Markhard AL; Panda A; Calvo SE; Deik A; Pan X; Zuckerman AL; Ben Saad A; Corey KE; Sjoquist J; Osganian S; AminiTabrizi R; Rhee EP; Shah H; Goldberger O; Mullen AC; Cracan V; Clish CB; Mootha VK; Goodman RP
    Cell Metab; 2024 Jan; 36(1):144-158.e7. PubMed ID: 38101397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exome-chip association analysis reveals an Asian-specific missense variant in PAX4 associated with type 2 diabetes in Chinese individuals.
    Cheung CY; Tang CS; Xu A; Lee CH; Au KW; Xu L; Fong CH; Kwok KH; Chow WS; Woo YC; Yuen MM; Hai JS; Jin YL; Cheung BM; Tan KC; Cherny SS; Zhu F; Zhu T; Thomas GN; Cheng KK; Jiang CQ; Lam TH; Tse HF; Sham PC; Lam KS
    Diabetologia; 2017 Jan; 60(1):107-115. PubMed ID: 27744525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The single nucleotide polymorphism rs499765 is associated with fibroblast growth factor 21 and nonalcoholic fatty liver disease in a Chinese population with normal glucose tolerance.
    Jiang S; Zhang R; Li H; Fang Q; Jiang F; Hou X; Hu C; Jia W
    J Nutrigenet Nutrigenomics; 2014; 7(3):121-9. PubMed ID: 25359230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P446L variant in GCKR associated with fasting plasma glucose and triglyceride levels exerts its effect through increased glucokinase activity in liver.
    Beer NL; Tribble ND; McCulloch LJ; Roos C; Johnson PR; Orho-Melander M; Gloyn AL
    Hum Mol Genet; 2009 Nov; 18(21):4081-8. PubMed ID: 19643913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated glucose represses liver glucokinase and induces its regulatory protein to safeguard hepatic phosphate homeostasis.
    Arden C; Petrie JL; Tudhope SJ; Al-Oanzi Z; Claydon AJ; Beynon RJ; Towle HC; Agius L
    Diabetes; 2011 Dec; 60(12):3110-20. PubMed ID: 22013014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general French population.
    Vaxillaire M; Cavalcanti-Proença C; Dechaume A; Tichet J; Marre M; Balkau B; Froguel P;
    Diabetes; 2008 Aug; 57(8):2253-7. PubMed ID: 18556336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Aryl Hydrocarbon Receptor Attenuates Fibroblast Growth Factor 21 Expression.
    Girer NG; Murray IA; Omiecinski CJ; Perdew GH
    J Biol Chem; 2016 Jul; 291(29):15378-87. PubMed ID: 27226639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete associations of the GCKR variant with metabolic risk in a Chinese population: longitudinal change analysis.
    Xu M; Lv X; Xie L; Huang X; Huang Y; Chen Y; Peng K; Wang P; Wang W; Qi L; Bi Y; Sun Y; Ning G
    Diabetologia; 2016 Feb; 59(2):307-15. PubMed ID: 26515422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The GCKR-P446L gene variant predisposes to raised blood cholesterol and lower blood glucose in the P446L mouse-a model for GCKR rs1260326.
    Ford BE; Chachra SS; Rodgers K; Moonira T; Al-Oanzi ZH; Anstee QM; Reeves HL; Schattenberg JM; Fairclough RJ; Smith DM; Tiniakos D; Agius L
    Mol Metab; 2023 Jun; 72():101722. PubMed ID: 37031802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common polymorphisms in MTNR1B, G6PC2 and GCK are associated with increased fasting plasma glucose and impaired beta-cell function in Chinese subjects.
    Tam CH; Ho JS; Wang Y; Lee HM; Lam VK; Germer S; Martin M; So WY; Ma RC; Chan JC; Ng MC
    PLoS One; 2010 Jul; 5(7):e11428. PubMed ID: 20628598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugar-sweetened beverage intake associations with fasting glucose and insulin concentrations are not modified by selected genetic variants in a ChREBP-FGF21 pathway: a meta-analysis.
    McKeown NM; Dashti HS; Ma J; Haslam DE; Kiefte-de Jong JC; Smith CE; Tanaka T; Graff M; Lemaitre RN; Rybin D; Sonestedt E; Frazier-Wood AC; Mook-Kanamori DO; Li Y; Wang CA; Leermakers ETM; Mikkilä V; Young KL; Mukamal KJ; Cupples LA; Schulz CA; Chen TA; Li-Gao R; Huang T; Oddy WH; Raitakari O; Rice K; Meigs JB; Ericson U; Steffen LM; Rosendaal FR; Hofman A; Kähönen M; Psaty BM; Brunkwall L; Uitterlinden AG; Viikari J; Siscovick DS; Seppälä I; North KE; Mozaffarian D; Dupuis J; Orho-Melander M; Rich SS; de Mutsert R; Qi L; Pennell CE; Franco OH; Lehtimäki T; Herman MA
    Diabetologia; 2018 Feb; 61(2):317-330. PubMed ID: 29098321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pleiotropic Effects of Common and Rare
    Yeh KH; Hsu LA; Teng MS; Wu S; Chou HH; Ko YL
    Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population.
    Qi Q; Wu Y; Li H; Loos RJ; Hu FB; Sun L; Lu L; Pan A; Liu C; Wu H; Chen L; Yu Z; Lin X
    Diabetologia; 2009 May; 52(5):834-43. PubMed ID: 19241058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GCKR and GCK polymorphisms are associated with increased risk of end-stage kidney disease in Chinese patients with type 2 diabetes: The Hong Kong Diabetes Register (1995-2019).
    Wang K; Shi M; Yang A; Fan B; Tam CHT; Lau E; Luk AOY; Kong APS; Ma RCW; Chan JCN; Chow E
    Diabetes Res Clin Pract; 2022 Nov; 193():110118. PubMed ID: 36243233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.